AboutEric Brandt Expertise I am a practicing pharmacist.On my drug information website, I have answered hundreds of questions to date. The articles posted on my site include Parkinson`s disease. depression, menopause, diabetes, sleep and aging, congestive heart failure, calcium channel blockers, thyroid hormone replacement therapy, ADHD, multiple sclerosis an more.
Experience I have experience in retail as well as hospital pharmacy pracice. Currently working in a hospital pharmacy. I am experienced in drug information. Over the last 6 years I have developed a successful web site for drug information.
The addressfor my drug information website is http://www.druginformation.bc.caThere you can read articles on varios areas of health interest. You can also leave me questions which I will personally answer. I also have a free health information newsletter called The Caplet. To subscribe send e-mail to
thecaplet-subscribe@topica.com
Question I recently asked a question regarding a side effect of accutane. The side effect I refer to is "premature closure of epiphysis". I have sought at least 6 medical opinions regarding this. All have been that this side effect is extremely rare and unlikely.
I am researching this subject as my 14 year old son is currently taking accutane. It is a last resort after using several antibiotics and prescription creams for the past 2 years. There is a concern about scarring as things have worsened. His doctors and I agreed that the risk of growth plate closure is minimal but the risk of scarring is probable w/o the accutane.
Anyway, my question is: how do the myriad of side effects get listed on the drug precaution sheet? There are no percentages listed regarding how many people have experienced growth plate closure. Is it because it is anecdotal stories or are there a lack of studies regarding this side effect?
I have searched for months for scientific studies on this subject. All I can find are stories on the internet from random individuals saying they did not grow, and then I can also find stories from random individuals saying they did grow?
What is the best way to make a good decision on these side effects?
Answer Hi Lor,
Here is what the manufacturer has to say about this topic.
Hyperostosis: Due to possible occurrence of bone changes, a careful evaluation of the risk/benefit ratio should be carried out in every patient and isotretinoin administration should be restricted to severe cases of acne. In clinical trials of disorders of keratinization, with a mean dose of2.24mg/kg/day, a high prevalence of skeletal hyperostosis was noted. Two children showed x-ray findings suggestive of premature closure of the epiphysis. Additionally, skeletal hyperostosis was noted in 6of8patients in a prospective study of disorders of keratinization. Minimal skeletal hyperostosis has also been observed by x-rays in prospective studies of cystic acne patients treated with a single course of therapy at recommended doses.
The above was a quote from the product monograph.
As you already determined it is hard to nail them down for frequency of this side effect.
Other side effects they list do have numbers associated with them.
My sense is that this is not a common side effect. I have not heard of it from anyone I have had on this nedication.
My own son was on it for a short period and he is of average height for our family.
I think that if this is the last resort because all other measures were ineffecive and the scarring is disfiguring then try it at least for a short period. We chose a period when school was out (summertime) so if there were any side effects, they would not interfere with schooling.
Once we were satisfied things were going well we continued into the school year with no ill effects that interfered with school. Peeling of skin and dryness of lips is common.
Thank you for using Allexperts
Sincerely,
Eric Brandt, B.Sc. Pharm
